Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia.

Radiation protection dosimetry - 1 Jan 2008

Schrappe Martin

Abstract excerpt

Systematic enrollment of children and adolescents with acute lymphoblastic leukaemia (ALL) into clinical trials has allowed the establishment of prognostic parameters derived from initial diagnostic findings. More important, these trials have significantly contributed to the reduction of disease recurrence as much as to the reduction of acute and late side effects. Some problems that are related to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child, Preschool
Share to Clinical Trials as Topic
Share to Disease Outbreaks

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Incidence

Share to Infant

Share to Infant, Newborn

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Risk Assessment

Source

Identifiers

PMID: 19017727
DOI: 10.1093/rpd/ncn289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia.PMID 19017727Read ↗

The biology and therapy of adult acute lymphoblastic leukemia.Semantic proximity Read ↗

Recent advances in the management of pediatric acute lymphoblastic leukemiaSemantic proximity Read ↗

Biology and treatment of acute lymphoblastic leukemia.Semantic proximity Read ↗

Novel clinical trials for pediatric leukemias: lessons learned from genomic analyses.Semantic proximity Read ↗

Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials.Semantic proximity Read ↗

Childhood and adolescent lymphoid and myeloid leukemia.Semantic proximity Read ↗

How can we improve on the already impressive results in pediatric ALL?Semantic proximity Read ↗

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

Childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Detection of minimal residual disease in pediatric acute lymphoblastic leukemiaSemantic proximity Read ↗

Molecular Determinants of Treatment Response in Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

In search of Pinkel's children: unravelling the biological heterogeneity of childhood acute lymphoblastic leukaemia by genotype and treatment molecular response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.